PharVision Advisers’s 1-800-Flowers.com FLWS Stock Holding History

PharVision Advisers’s Portfolio FLWS Stock Details FLWS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,680	Closed	-$37.2K	–	41
2026 Q2	$37.2K	Buy	+10,680	New	+$42.1K	0.7%	61
2025 Q4	–	Sell	-34,044	Closed	-$157K	–	789
2025 Q3	$157K	Buy	+34,044	New	+$188K	0.09%	562
2025 Q2	–	Sell	-18,590	Closed	-$110K	–	330
2025 Q1	$110K	Buy	+18,590	New	+$137K	0.15%	244

Other funds holding FLWS

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

PharVision Advisers's FLWS Position: Q3 2026 in Review

PharVision Advisers sold out of 1-800-Flowers.com (FLWS) in Q3 2026, closing a stake of 10,680 shares — an estimated $37.2K sold.

PharVision Advisers first reported a position in FLWS in Q1 2025 and held it in 3 quarters. The position peaked at $157K in Q3 2025. 24 funds tracked by Wall St. Rank hold FLWS as of Q3 2026.

PharVision Advisers reported no remaining 1-800-Flowers.com position as of Q3 2026 after selling out during the quarter.
PharVision Advisers sold 10,680 1-800-Flowers.com shares in Q3 2026, an estimated $37.2K.
PharVision Advisers first reported a position in 1-800-Flowers.com in Q1 2025 and held it in 3 quarters.
PharVision Advisers's 1-800-Flowers.com position peaked at $157K in Q3 2025.
24 funds tracked by Wall St. Rank held 1-800-Flowers.com as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.